TScan Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRX and other ETFs, options, and stocks.

About TCRX

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts.

CEO

Gavin MacBeath

CEOGavin MacBeath

Employees

194

Employees194

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2018

Founded2018

Employees

194

Employees194

TCRX Key Statistics

Market cap

70.17M

Market cap70.17M

Price-Earnings ratio

-1.14

Price-Earnings ratio-1.14

Dividend yield

—

Dividend yield—

Average volume

267.28K

Average volume267.28K

High today

$1.33

High today$1.33

Low today

$1.23

Low today$1.23

Open price

$1.30

Open price$1.30

Volume

311.35K

Volume311.35K

52 Week high

$9.69

52 Week high$9.69

52 Week low

$1.02

52 Week low$1.02

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own TCRX. This list is generated using Robinhood data, and it’s not a recommendation.